Cryoport Inc (NASDAQ:CYRX) reported third-quarter financial results after the market close on Tuesday. Here’s a rundown of the temperature-controlled supply chain solutions company’s report.

CYRX is holding steady in today’s choppy market. See if it is worth your attention here.

Q3 Highlights: Cryoport reported third-quarter revenue of $44.2 million, beating analyst estimates of $41.36 million, according to Benzinga Pro. The company reported a third-quarter loss of 18 cents per share, beating estimates for a loss of 21 cents per share.

Total revenue was up 15% on a year-over-year basis as Commercial Cell and Gene Therapy revenue increased 36%. Here’s a breakdown of revenue by category.

Life ...